Physician profile
Neil Harrison
NPI 1093133530
$1,019.36
in general payments reported to CMS, 2019-2025
9 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $314 · 2021: $24.74 · 2022: $76.96 · 2023: $50.16 · 2024: $139 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $267.85 | 2020 | |
| Sirtex Medical INC | $253.28 | 2025 | Sir-Spheres Microspheres |
| Boston Scientific Corporation | $216.64 | 2022-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Galvanize Therapeutics, INC | $99.85 | 2025 | Aliya System |
| Philips North America LLC | $67.42 | 2020-2025 | Spectral Ct 7500 |
| Medtronic, INC. | $40.44 | 2024 | Abre |
| Terumo Medical Corporation | $39.14 | 2024-2025 | Azur Cx Detachable, Navicross, Hydropearl |
| Stryker Corporation | $24.74 | 2021 | |
| Merit Medical Systems INC | $10.00 | 2024 | Corvocet Biopsy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.